8 Effects of sex steroids on serum lipids and lipoproteins

Adami, 1990, Long-term effects of transdermal and oral oestrogen on serum lipoproteins in postmenopausal women, 238 Bain, 1981, Use of postmenopausal hormones and risk of myocardial infarction, Circulation, 64, 42, 10.1161/01.CIR.64.1.42 Basdevant, 1983, Differential lipemic and hormonal responses to oral and parenteral 17β-oestradiol in postmenopausal women, American Journal of Obstetrics and Gynecology, 147, 77, 10.1016/0002-9378(83)90088-1 Bengtsson, 1978, Coronary heart disease during the menopause, 234 Blanc, 1977, Menopause and myocardial infarction, American Journal of Obstetrics and Gynecology, 127, 353, 10.1016/0002-9378(77)90489-6 Bonithon-Kopp, 1990, Menopause-related changes in lipoproteins and some other cardiovascular risk factors, International Journal of Epidemiology, 19, 42, 10.1093/ije/19.1.42 Bush, 1987, Cardiovascular mortality and noncontraceptive use of oestrogen in women: results from the Lipid Research Clinics Program Follow-up Study, Circulation, 75, 1102, 10.1161/01.CIR.75.6.1102 Bush, 1987, Effects of pharmacologic agents used during menopause: Impact on lipids and lipoproteins, 187 Bush, 1984, Ovarian function and lipid/lipoprotein levels. Results from the Lipid Research Clinics Program, American Journal of Epidemiology, 120, 489 Bush, 1988, Cholesterol, lipoproteins, and coronary heart disease in women, Clinical Chemistry, 34, B60 Castelli, 1986, Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study, Journal of the American Medical Association, 256, 2835, 10.1001/jama.1986.03380200073024 Chetkowski, 1986, Biologic effects of transdermal estradiol, New England Journal of Medicine, 314, 1615, 10.1056/NEJM198606193142505 Connor, 1982, The effects of age, body weight and family relationships on plasma lipoproteins and lipids in men, women, and children of randomly selected families, Circulation, 65, 1290, 10.1161/01.CIR.65.7.1290 Colditz, 1987, Menopause and the risk of coronary heart disease in women, New England Journal of Medicine, 316, 1105, 10.1056/NEJM198704303161801 Consensus Report, 1988, Progestagen use in postmenopausal women, Lancet, ii, 1243 Egeland, 1990, Hormone replacement therapy and lipoprotein changes during early menopause, Obstetrics and Gynecology, 76, 776, 10.1097/00006250-199011000-00010 Elkik, 1982, Effects of percutaneous estradiol and conjugated estrogens on the level of plasma proteins and triglycerides in postmenopausal women, American Journal of Obstetrics and Gynecology, 143, 888, 10.1016/0002-9378(82)90468-9 Fåhreaus, 1983, High density lipoprotein subfractions during oral and cutaneous administration of 17β-oestradiol to menopausal women, Journal of Clinical Endocrinology and Metabolism, 56, 797, 10.1210/jcem-56-4-797 Fåhreaus, 1982, Lipoproteins during oral and cutaneous administration of oestradiol-17β to menopausal women, Acta Endocrinologica, 101, 597, 10.1530/acta.0.1010597 Fåhreaus, 1983, L-Norgestrel and progesterone have different influences on plasma lipoproteins, European Journal of Clinical Investigation, 13, 447, 10.1111/j.1365-2362.1983.tb00127.x Farish, 1984, The effects of hormone implants on serum lipoproteins and steroid hormones in bilaterally oophorectomised women, Acta Endocrinologica, 106, 116, 10.1530/acta.0.1060116 Farish, 1986, The effects of conjugated equine oestrogens with and without a cyclical progestogen on lipoproteins and HDL subfractions in postmenopausal women, Acta Endocrinologica, 113, 123, 10.1530/acta.0.1130123 Farish, 1989, Lipoprotein and apolipoprotein levels in postmenopausal women on continuous oestrogen/progestogen therapy, British Journal of Obstetrics and Gynaecology, 96, 358, 10.1111/j.1471-0528.1989.tb02398.x Farish, 1990, Effects of bilateral oophorectomy on lipoprotein metabolism, British Journal of Obstetrics and Gynaecology, 97, 78, 10.1111/j.1471-0528.1990.tb01721.x Fletcher, 1986, Long-term hormone implant therapy—effects on lipoproteins and steroid level in post-menopausal women, Acta Endocrinologica, 111, 419, 10.1530/acta.0.1110419 Fletcher, 1987, A comparison of the effects of lipoproteins of two progestogens used during cyclical hormone replacement therapy, Maturitas, 9, 253, 10.1016/0378-5122(87)90007-7 Gambrell, 1983, Role of oestrogens and progesterone in the etiology and prevention of endometrial cancer: Review, American Journal of Obstetrics and Gynecology, 146, 696, 10.1016/0002-9378(83)91014-1 Gibbons, 1986, Biochemical and histologic effects of sequential estrogen/progestin therapy on the endometrium of postmenopausal women, American Journal of Obstetrics and Gynecology, 154, 456, 10.1016/0002-9378(86)90690-3 Goebelsmann, 1985, Comparison of hepatic impact of oral and vaginal administration of ethinyl estradiol, American Journal of Obstetrics and Gynecology, 151, 868, 10.1016/0002-9378(85)90664-7 Gordon, 1977, The prediction of coronary heart disease by high-density and other lipoproteins: An historical perspective, 71 Gordon, 1977, High density lipoproteins as a protective factor against coronary heart disease. The Framingham Study, American Journal of Medicine, 62, 707, 10.1016/0002-9343(77)90874-9 Gordon, 1978, Menopause and coronary heart disease. The Framingham Study, Annals of Internal Medicine, 89, 157, 10.7326/0003-4819-89-2-157 Haarbo, 1991, Serum lipids, lipoproteins, and apolipoproteins during postmenopausal estrogen replacement therapy combined with either 19-nortestosterone derivatives or 17-hydroxyprogesterone derivatives, American Journal of Medicine, 90, 584, 10.1016/S0002-9343(05)80009-9 Hammond, 1979, Effects of long-term estrogen replacement therapy. II. Neoplasia, American Journal of Obstetrics and Gynecology, 133, 537, 10.1016/0002-9378(79)90289-8 Hargrove, 1989, Menopausal hormone replacement therapy with continuous daily oral micronized estradiol and progesterone, Obstetrics and Gynecology, 73, 606 Heiss, 1980, Lipoprotein-cholesterol distributions in selected North American populations: The Lipid Research Clinics Program Prevalence Study, Circulation, 61, 302, 10.1161/01.CIR.61.2.302 Henderson, 1988, Estrogen replacement therapy and protection from acute myocardial infarction, American Journal of Obstetrics and Gynecology, 159, 312, 10.1016/S0002-9378(88)80074-7 Hirvonen, 1981, Effects of different progestogens on lipoproteins during postmenopausal replacement therapy, New England Journal of Medicine, 304, 560, 10.1056/NEJM198103053041002 Hirvonen, 1987, Clinical and lipid metabolic effects of unopposed oestrogen and two oestrogen-progestogen regimens in postmenopausal women, Maturitas, 9, 69, 10.1016/0378-5122(87)90054-5 Hirvonen, 1990, Comparison of two hormone replacement regimens—influence on lipoproteins and bone mineral content, Maturitas, 12, 127, 10.1016/0378-5122(90)90091-J Hjortland, 1976, Some atherogenic concomitants of menopause: The Framingham Study, American Journal of Epidemiology, 103, 304, 10.1093/oxfordjournals.aje.a112228 Holst, 1983, A comparison of liver protein induction in postmenopausal women during oral and percutaneous oestrogen replacement therapy, British Journal of Obstetrics and Gynaecology, 90, 355, 10.1111/j.1471-0528.1983.tb08923.x Hulley, 1980, Epidemiology as a guide to clinical decisions. The association between triglycerides and coronary heart disease, New England Journal of Medicine, 302, 1383, 10.1056/NEJM198006193022503 Jensen, 1986, Cyclic changes in serum cholesterol and lipoproteins following different doses of combined postmenopausal hormone replacement therapy, British Journal of Obstetrics and Gynaecology, 92, 613, 10.1111/j.1471-0528.1986.tb08035.x Jensen, 1987, Dose-response effects on serum lipids and lipoproteins following combined oestrogen-progestogen therapy in postmenopausal women, Maturitas, 9, 259, 10.1016/0378-5122(87)90008-9 Jensen, 1987, Cyproterone acetate, an alternative progestogen in postmenopausal hormone replacement therapy? Effects on serum lipids and lipoproteins, British Journal of Obstetrics and Gynaecology, 94, 136, 10.1111/j.1471-0528.1987.tb02340.x Jensen, 1987, Continuous oestrogen-progestogen treatment and serum lipoproteins in postmenopausal women, British Journal of Obstetrics and Gynaecology, 94, 130, 10.1111/j.1471-0528.1987.tb02339.x Jensen, 1987, Long-term effects of percutaneous estrogens and oral progesterone on serum lipoproteins in postmenopausal women, American Journal of Obstetrics and Gynecology, 156, 66, 10.1016/0002-9378(87)90204-3 Jensen, 1989, Long-term and withdrawal effects of two different oestrogen-progestogen combinations on lipid and lipoprotein profiles in postmenopausal women, Maturitas, 11, 117, 10.1016/0378-5122(89)90004-2 Jensen, 1990, The influence of menopause on serum lipids and lipoproteins, Maturitas, 12, 321, 10.1016/0378-5122(90)90012-U Jick, 1978, Noncontraceptive estrogens and nonfatal myocardial infarction, Journal of the American Medical Association, 239, 1407, 10.1001/jama.1978.03280410049017 Kannel, 1987, Cardiovascular effects of the menopause, 91 Kannel, 1971, Serum cholesterol, lipoproteins, and the risk of coronary heart disease. The Framingham Study, Annals of Internal Medicine, 74, 1, 10.7326/0003-4819-74-1-1 Kissebah, 1973, Mechanism of hypertriglyceridaemia associated with contraceptive steroids, Hormone and Metabolic Research, 5, 184, 10.1055/s-0028-1093969 Klorfajn, 1978, A study on serum lipids of the elderly, Journal of Gerontology, 33, 48, 10.1093/geronj/33.1.48 Kovanen, 1979, Increased binding of low density lipoprotein to liver membranes from rats treated with 17α-ethinyl estradiol, Journal of Biological Chemistry, 254, 11367, 10.1016/S0021-9258(19)86495-5 Krauss, 1988, Effects of estrogen dose and smoking on lipid and lipoprotein levels in postmenopausal women, American Journal of Obstetrics and Gynecology, 158, 1606, 10.1016/0002-9378(88)90198-6 Lagrelius, 1986, Clinical experience with a low-dose combination of estradiol valerate and levonorgestrel, Acta Obstetrica et Gynecologica Scandinavica, 134, 97, 10.3109/00016348609157056 Lane, 1983, Dose dependent effects of oral progesterone on the oestrogenized postmenopausal endometrium, British Medical Journal, 287, 1241, 10.1136/bmj.287.6401.1241 Lapidus, 1985, Menopausal age and risk of cardiovascular disease and death, Acta Obstetrica et Gynecologica Scandinavica, 130, 37, 10.3109/00016348509157145 Lapidus, 1985, Triglycerides—main lipid risk factor for cardiovascular disease in women?, Acta Medica Scandinavica, 217, 481, 10.1111/j.0954-6820.1985.tb03251.x Lindgren, 1990, Plasma lipids and lipoproteins in climacteric women treated with sequential transdermal patches containing 17β-oestradiol and 17β-oestradiol/norethisterone, 282 Lindquist, 1982, Intraindividual changes of blood pressure, serum lipids, and body weight in relation to menstrual status: Results from a prospective population study of women in Göteborg, Preventive Medicine, 11, 162, 10.1016/0091-7435(82)90015-9 Lindquist, 1980, Serum lipids, arterial blood pressure and body weight in relation to the menopause: results from a population study of women in Göteborg, Sweden, Scandinavian Journal of Clinical and Laboratory Investigation, 40, 629, 10.3109/00365518009091974 Lipid Research Clinics Program, 1984, The Lipid Research Clinics Coronary Primary Prevention Trial Results. II. The relationship of reduction in incidence of coronary heart disease to cholesterol lowering, Journal of the American Medical Association, 251, 365, 10.1001/jama.1984.03340270043026 Manchester, 1971, Premenopausal castration and documented coronary atherosclerosis, American Journal of Cardiology, 28, 33, 10.1016/0002-9149(71)90031-2 Mandel, 1983, Biological effects of various doses of vaginally administered conjugated equine estrogens in postmenopausal women, Journal of Clinical Endocrinology and Metabolism, 57, 133, 10.1210/jcem-57-1-133 Marslew, 1991, Desogestrel in hormone replacement therapy: Long-term effects on bone, calcium and lipid metabolism, climacteric symptoms, and bleeding, European Journal of Clinical Investigation, 10.1111/j.1365-2362.1991.tb01416.x Marslew, 1991, Two new combinations of oestrogen and progestogen for prevention of postmenopausal bone loss. Long-term effects on bone, calcium and lipid metabolism, climacteric symptoms, and bleeding, British Journal of Obstetrics and Gynaecology Martin, 1986, Serum cholesterol, blood pressure, and mortality: Implications from a cohort of 361 662 men, Lancet, ii, 933, 10.1016/S0140-6736(86)90597-0 Matthews, 1989, Menopause and risk factors for coronary heart disease, New England Journal of Medicine, 321, 641, 10.1056/NEJM198909073211004 Mattsson, 1982, Evaluation of a continuous oestrogen-progestogen regimen for climacteric complaints, Maturitas, 4, 95, 10.1016/0378-5122(82)90035-4 Mattsson, 1984, A continuous estrogen-progestogen regimen for climacteric complaints. Effects on lipid and lipoprotein metabolism, Acta Obstetrica et Gynecologica Scandinavica, 63, 673, 10.3109/00016348409154661 Miller, 1987, Associations of high-density lipoprotein subclasses and apolipoproteins with ischaemic heart disease and coronary atherosclerosis, American Heart Journal, 113, 589, 10.1016/0002-8703(87)90638-7 Miller, 1977, The Tromsø Heart Study. High density lipoprotein and coronary heart disease: A prospective case-control study, Lancet, i, 965, 10.1016/S0140-6736(77)92274-7 Notelovitz, 1982, Oestrogen-progestin therapy and the lipid balance of post-menopausal women, Maturitas, 4, 301, 10.1016/0378-5122(82)90062-7 Ottosson, 1985, Subfractions of high-density lipoprotein cholesterol during estrogen replacement therapy: A comparison between progestogens and natural progesterone, American Journal of Obstetrics and Gynecology, 151, 746, 10.1016/0002-9378(85)90509-5 Persson, 1986, The risk of endometrial neoplasia and treatment with estrogen-progestogen combinations, Acta Obstetrica et Gynecologica Scandinavica, 65, 211, 10.3109/00016348609155173 Prough, 1987, Continuous estrogen/progestin therapy in menopause, American Journal of Obstetrics and Gynecology, 157, 1449, 10.1016/S0002-9378(87)80242-9 Rijpkema, 1990, Effects of post-menopausal oestrogen-progestogen replacement therapy on serum lipids and lipoproteins: a review, Maturitas, 12, 259, 10.1016/0378-5122(90)90007-S Rosenberg, 1981, Early menopause and the risk of myocardial infarction, American Journal of Obstetrics and Gynecology, 139, 47, 10.1016/0002-9378(81)90410-5 Ross, 1981, Menopausal oestrogen therapy and protection from death from ischaemic heart disease, Lancet, i, 858, 10.1016/S0140-6736(81)92138-3 Schaefer, 1983, The effects of estrogen administration on plasma lipoprotein metabolism in premenopausal females, Journal of Clinical Endocrinology and Metabolism, 57, 262, 10.1210/jcem-57-2-262 Sharf, 1985, Lipid and lipoprotein levels following pure estradiol implantation in post-menopausal women, Gynecologic and Obstetric Investigation, 19, 207, 10.1159/000299035 Sherwin, 1989, A prospective one-year study of estrogen and progestin in postmenopausal women: Effects on clinical symptoms and lipoprotein lipids, Obstetrics and Gynecology, 73, 759 Sherwin, 1987, Postmenopausal estrogen and androgen replacement and lipoprotein lipid concentrations, American Journal of Obstetrics and Gynecology, 156, 414, 10.1016/0002-9378(87)90295-X Siddle, 1982, Dose-dependent effects of synthetic progestins on the biochemistry of the estrogenized post-menopausal endometrium, Acta Obstetrica et Gynecologica Scandinavica, 106, 17, 10.3109/00016348209155325 Silverstople, 1982, Lipid metabolic studies in oophorectomised women: effects on serum lipids and lipoproteins of three synthetic progestogens, Maturitas, 4, 103, 10.1016/0378-5122(82)90036-6 Silverstolpe, 1982, Lipid and carbohydrate metabolism studies in oophorectomized women: Effects produced by the addition of norethisterone acetate to two estrogen preparations, Archives of Gynecology, 231, 279, 10.1007/BF02111726 Sporrong, 1989, Metabolic effects of continuous estradiol-progestin therapy in postmenopausal women, Obstetrics and Gynecology, 73, 754 Staland, 1981, Continuous treatment with natural oestrogens and progestogens. A way of avoiding endometrial stimulation, Maturitas, 3, 145, 10.1016/0378-5122(81)90006-2 Stampfer, 1985, A prospective study of postmenopausal estrogen therapy and coronary heart disease, New England Journal of Medicine, 313, 1044, 10.1056/NEJM198510243131703 Stanczyk, 1988, A randomized comparison of nonoral estradiol delivery in postmenopausal women, American Journal of Obstetrics and Gynecology, 159, 1540, 10.1016/0002-9378(88)90591-1 Sullivan, 1988, Postmenopausal estrogen use and coronary atherosclerosis, Annals of Internal Medicine, 108, 358, 10.7326/0003-4819-108-3-358 Tikkanen, 1986, Post-menopausal hormone replacement therapy: effects of progestogens on serum lipids and lipoproteins. A review, Maturitas, 8, 7, 10.1016/0378-5122(86)90003-4 Tyroler, 1987, Review of lipid-lowering clinical trial in relation to observational epidemiologic studies, Circulation, 76, 515, 10.1161/01.CIR.76.3.515 Weinstein, 1987, Efficacy of a continuous estrogen-progestin regimen in the menopausal patient, Obstetrics and Gynecology, 69, 929 Whitehead, 1986, Prevention of endometrial abnormalities, Acta Obstetrica et Gynecologica Scandinavica, 134, 81, 10.3109/00016348609157054 Whitehead, 1981, Effects of estrogens and progestins on the biochemistry and morphology of the postmenopausal endometrium, New England Journal of Medicine, 305, 1599, 10.1056/NEJM198112313052701 Wilson, 1985, Postmenopausal estrogen use, cigarette smoking, and cardiovascular morbidity in women over 50. The Framingham Study, New England Journal of Medicine, 313, 1038, 10.1056/NEJM198510243131702 Witteman, 1989, Increased risk of atherosclerosis in women after the menopause, British Medical Journal, 298, 642, 10.1136/bmj.298.6674.642